SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

82,268.25 1,161.60
( 1.43%)

Global Indices

Nasdaq

52,245.46 -165.29
(-0.32%)

Dow Jones

7,531.52 -39.42
(-0.52%)

Hang Seng

60,560.79 1,785.29
(3.04%)

Nikkei 225

10,782.38 -0.49
(0.00%)

Forex

USD-INR

94.03 -0.38
(-0.40%)

EUR-INR

104.75 -1.32
(-1.24%)

GBP-INR

125.52 -1.66
(-1.31%)

JPY-INR

0.59 0.00
(-0.72%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ambalal Sarabhai Enterprises Ltd

Industry : Trading

BSE Code

ISIN Demat

Book Value()

500009

INE432A01017

7.7615866

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AMBALALSA

60.39

273.04

EPS(TTM)

Face Value()

Div & Yield %

0.59

Back

Novartis India reports standalone net loss of Rs 77.54 crore in the September 2026 quarter

Nov 04,2026

Net loss of Novartis India reported to Rs 77.54 crore in the quarter ended September 2026 as against net profit of Rs 24.22 crore during the previous quarter ended September 2025. Sales declined 37.95% to Rs 56.05 crore in the quarter ended September 2026 as against Rs 90.33 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	56.05	90.33	-38
OPM %	-56.77	26.44	-
PBDT	-28.91	33.17	PL
PBT	-32.80	32.65	PL
NP	-77.54	24.22	PL

82,268.25 1,161.60 ( 1.43%)

52,245.46 -165.29 (-0.32%)

7,531.52 -39.42 (-0.52%)

60,560.79 1,785.29 (3.04%)

10,782.38 -0.49 (0.00%)

94.03 -0.38 (-0.40%)

104.75 -1.32 (-1.24%)

125.52 -1.66 (-1.31%)

0.59 0.00 (-0.72%)